Aqueous humor levels of vasoactive molecules correlate with vitreous levels and macular edema in central retinal vein occlusion

European Journal of Ophthalmology

Volumn 20, Issue 2, 2010, Pages 402-409

  Noma, Hidetaka ^a,b   Funatsu, Hideharu ^a   Mimura, Tatsuya ^c   Harino, Seiyo ^d   Hori, Sadao ^e  

^a Tokyo Women s Medical University   (Japan)

^b HIROSHIMA UNIVERSITY   (Japan)

^c UNIVERSITY OF TOKYO   (Japan)

^d YODOGAWA CHRISTIAN HOSPITAL   (Japan)

^e TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

Author keywords

Central retinal vein occlusion; Interleukin 6; Macular edema; Vascular endothelial growth factor

Indexed keywords

INTERLEUKIN 6; VASCULOTROPIN;

ADULT; AGED; AQUEOUS HUMOR; ARTICLE; BLOOD BRAIN BARRIER; CENTRAL RETINA VEIN OCCLUSION; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; DISEASE SEVERITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; LASER COAGULATION; MALE; OPHTHALMOSCOPY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RETINA MACULA DEGENERATION; RETINA MACULA EDEMA; SLIT LAMP; THICKNESS; VISUAL ACUITY; VITRECTOMY; VITREOUS BODY;

EID: 77952816998     PISSN: 11206721     EISSN: None     Source Type: Journal    
DOI: 10.1177/112067211002000222     Document Type: Article

References (40)

1. Zegara H, Gutman FA, Conforto J. The natural course of central retinal vein occlusion. Ophthalmology 1979; 86: 1931-1942 (Pubitemid 10004904)
2. Hayreh SS. Classification of central retinal vein occlusion. Ophthalmology 1983; 90: 458-474 (Pubitemid 13059774)
3. Gutman FA, Zegarra H. Macular edema secondary to occlusion of the retinal veins. Surv Ophthalmol 1984; 28 Suppl: 462-470 (Pubitemid 14076505)
4. Aiello LP, Avery RL, Arrigg PG, et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331: 1480-1487
5. Chen KH, Wu CC, Roy S, Lee SM, Liu JH. Increased interleukin-6 in aqueous humor of neovascular glaucoma. Invest Ophthalmol Vis Sci 1999; 40: 2627-2632 (Pubitemid 29455493)
6. Pe'er J, Folberg R, Itin A, Gnessin H, Hemo I, Keshet E. Vascular endothelial growth factor upregulation in human central retinal vein occlusion. Ophthalmology 1998; 105: 412-416
7. Noma H, Funatsu H, Mimura T, Harino S, Sone T, Hori S. Increase of vascular endothelial growth factor and interleukin-6 in the aqueous humour of patients with macular oedema and central retinal vein occlusion. Acta Ophthalmol 2009 June 26 [Epub ahead of print].
8. Leizaola-Fernandez C, Suarez-Tata L, Quiroz-Mercado H, et al. Vitrectomy with complete posterior hyaloid removal for ischemic central retinal vein occlusion: series of cases. BMC Ophthalmol 2005; 5: 10. (Pubitemid 41074246)
9. Tachi N, Hashimoto Y, Ogino N. Vitrectomy for macular edema combined with retinal vein occlusion. Doc Ophthalmol 1999; 97: 465-469 (Pubitemid 30410122)
10. Noma H, Funatsu H, Yamasaki M, et al. Pathogenesis of macular edema with branch retinal vein occlusion and intraocular levels of vascular endothelial growth factor and interleukin-6. Am J Ophthalmol 2005; 140: 256-261 (Pubitemid 41125805)
11. Noma H, Minamoto A, Funatsu H, et al. Intravitreal levels of vascular endothelial growth factor and interleukin-6 are correlated with macular edema in branch retinal vein occlusion. Graefes Arch Clin Exp Ophthalmol 2006; 244: 309-315 (Pubitemid 41125805)
12. Noma H, Funatsu H, Yamasaki M, et al. Aqueous humour levels of cytokines are correlated to vitreous levels and severity of macular oedema in branch retinal vein occlusion. Eye 2008; 22: 42-48
13. Baseline and early natural history report. The Central Vein Occlusion Study. Arch Ophthalmol 1993; 111: 1087-1095
14. Evaluation of grid pattern photocoagulation for macular edema in central vein occlusion. The Central Vein Occlusion Study Group M report. Ophthalmology 1995; 102: 1425-1433
15. Natural history and clinical management of central retinal vein occlusion. The Central Vein Occlusion Study Group. Arch Ophthalmol 1997; 115: 486-491 (Pubitemid 27172704)
16. Otani T, Kishi S. Tomographic assessment of vitreous surgery for diabetic macular edema. Am J Ophthalmol 2000; 129: 487-494 (Pubitemid 30184920)
17. Schepens CL, Avila MP, Jalkh AE, Trempe CL. Role of the vitreous in cystoid macular edema. Surv Ophthalmol 1984; 28 (Suppl): S499-504.
18. Mandelcorn MS, Mandelcorn E, Guan K, Adatia FA. Surgical macular decompression for macular edema in retinal vein occlusion. Can J Ophthalmol 2007; 42: 116-122 (Pubitemid 46408905)
19. Behzadian MA, Wang XL, Shabrawey M, Caldwell RB. Effects of hypoxia on glial cell expression of angiogenesis-regulating factors VEGF and TGF-beta. Glia 1998; 24: 216-225 (Pubitemid 28403999)
20. Funatsu H, Yamashita H, Noma H, et al. Aqueous humor levels of cytokines are related to vitreous levels and progression of diabetic retinopathy in diabetic patients. Graefes Arch Clin Exp Ophthalmol 2005; 243: 3-8.
21. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992; 13: 18-32.
22. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW. The vascular endothelial growth factor family: identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 1991; 5: 1806-1814
23. Tischer E, Mitchell R, Hartman T, et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991; 266: 11947-11954 (Pubitemid 21907041)
24. Park JE, Keller GA, Ferrara N. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol Biol Cell 1993; 4: 1317-1326 (Pubitemid 24045761)
25. Miyake K, Miyake T, Kayazawa F. Blood-aqueous barrier in eyes with retinal vein occlusion. Ophthalmology 1992; 99: 906-910
26. Nguyen NX, Kuchle M. Aqueous flare and cells in eyes with retinal vein occlusion: correlation with retinal fluorescein angiographic findings. Br J Ophthalmol 1993; 77: 280-283 (Pubitemid 23177356)
27. Hangai M, Yoshimura N, Honda Y. Increased cytokine gene expression in rat retina following transient ischemia. Ophthalmic Res 1996; 28: 248-254 (Pubitemid 26294398)
28. Yan SF, Tritto I, Pinsky D, et al. Induction of interleukin 6 (IL-6) by hypoxia in vascular cells. Central role of the binding site for nuclear factor-IL-6. J Biol Chem 1995; 270: 11463-11471
29. Frangogiannis NG, Lindsey ML, Michael LH, et al. Resident cardiac mast cells degranulate and release preformed TNF-alpha, initiating the cytokine cascade in experimental canine myocardial ischemia/reperfusion. Circulation 1998; 98: 699-710.
30. Frangogiannis NG, Ren G, Dewald O, et al. Critical role of endogenous thrombospondin-1 in preventing expansion of healing myocardial infarcts. Circulation 2005; 111: 2935-2942
31. Li Y, Stechschulte AC, Smith DD, Lindsley HB, Stechschulte DJ, Dileepan KN. Mast cell granules potentiate endotoxin-induced interleukin-6 production by endothelial cells. J Leukoc Biol 1997; 62: 211-216
32. Aiello LP, Northrup JM, Keyt BA, Takagi H, Iwamoto MA. Hypoxic regulation of vascular endothelial growth factor in retinal cells. Arch Ophthalmol 1995; 113: 1538-1544
33. Vinores SA, Derevjanik NL, Ozaki H, Okamoto N, Campochiaro PA. Cellular mechanisms of blood-retinal barrier dysfunction in macular edema. Doc Ophthalmol 1999; 97: 217-228
34. Gardner TW, Antonetti DA, Barber AJ, Lieth E, Tarbell JA. The molecular structure and function of the inner blood-retinal barrier. Penn State Retina Research Group. Doc Ophthalmol 1999; 97: 229-237
35. Maruo N, Morita I, Shirao M, Murota S. IL-6 increases endothelial permeability in vitro. Endocrinology 1992; 131: 710-714
36. Desai TR, Leeper NJ, Hynes KL, Gewertz BL. Interleukin-6 causes endothelial barrier dysfunction via the protein kinase C pathway. J Surg Res 2002; 104: 118-123
37. Tolentino MJ, Miller JW, Gragoudas ES, et al. Intravitreous injections of vascular endothelial growth factor produce retinal ischemia and microangiopathy in an adult primate. Ophthalmology 1996; 103: 1820-1828
38. Iturralde D, Spaide RF, Meyerle CB, et al. Intravitreal bevacizumab (Avastin) treatment of macular edema in central retinal vein occlusion: a short-term study. Retina 2006; 26: 279-284
39. Pai SA, Shetty R, Vijayan PB, et al. Clinical, anatomic, and electrophysiologic evaluation following intravitreal bevacizumab for macular edema in retinal vein occlusion. Am J Ophthalmol 2007; 143: 601-606
40. Campochiaro PA, Hafiz G, Shah SM, et al. Ranibizumab for macular edema due to retinal vein occlusions: implication of VEGF as a critical stimulator. Mol Ther 2008; 16: 791-799